Xu L - Search Results

1

The Potential of Alkyl Amides as Novel Biomarkers and Their Application to Paleocultural Deposits in China.

Wang J, Simoneit BRT, Sheng G, Chen L, Xu L, Wang X, Wang Y, Sun L. Wang J, et al. Among authors: xu l. Sci Rep. 2017 Nov 7;7(1):14667. doi: 10.1038/s41598-017-15371-z. Sci Rep. 2017. PMID: 29116260 Free PMC article.

2

The abrupt climate change near 4,400 yr BP on the cultural transition in Yuchisi, China and its global linkage.

Wang J, Sun L, Chen L, Xu L, Wang Y, Wang X. Wang J, et al. Among authors: xu l. Sci Rep. 2016 Jun 10;6:27723. doi: 10.1038/srep27723. Sci Rep. 2016. PMID: 27283832 Free PMC article.

3

Heavy metal distribution in Tiaoxi River's sediment.

Zheng B, Lu S, Wu J, Guo X, Wu F, Li X, He Q, Fu Z, Xu L. Zheng B, et al. Among authors: xu l. Environ Sci Pollut Res Int. 2018 Jan;25(3):2603-2613. doi: 10.1007/s11356-017-0332-4. Epub 2017 Nov 12. Environ Sci Pollut Res Int. 2018. PMID: 29130130

4

Relationship between (210)Pb(ex) activity and sedimentary organic carbon in sediments of 3 Chinese lakes.

Xu L, Wu F, Wan G, Liao H, Zhao X, Xing B. Xu L, et al. Environ Pollut. 2011 Dec;159(12):3462-7. doi: 10.1016/j.envpol.2011.08.020. Epub 2011 Sep 1. Environ Pollut. 2011. PMID: 21889244

5

A Neural-Network-Based Mapping and Optimization Framework for High-Precision Coarse-Grained Simulation.

Zhong Z, Xu L, Jiang J. Zhong Z, et al. Among authors: xu l. J Chem Theory Comput. 2025 Jan 9. doi: 10.1021/acs.jctc.4c01466. Online ahead of print. J Chem Theory Comput. 2025. PMID: 39782000

6

Development of a Novel four-gene Model for Monitoring the Progression from Metabolic Dysfunction-associated Steatotic Liver Disease to Hepatocellular Carcinoma in Males.

Jiang Y, Chen J, Xu L, Lv L, Gan X. Jiang Y, et al. Among authors: xu l. J Cancer. 2025 Jan 1;16(3):917-931. doi: 10.7150/jca.100724. eCollection 2025. J Cancer. 2025. PMID: 39781352 Free PMC article.

7

Exosomes of stem cells: a potential frontier in the treatment of osteoarthritis.

Wang X, Xu L, Wu Z, Lou L, Xia C, Miao H, Dai J, Fei W, Wang J. Wang X, et al. Among authors: xu l. Precis Clin Med. 2024 Nov 26;8(1):pbae032. doi: 10.1093/pcmedi/pbae032. eCollection 2025 Mar. Precis Clin Med. 2024. PMID: 39781279 Free PMC article. Review.

8

Cross-cultural adaptation of the simple Chinese version of the medication adherence reasons scale in patients undergoing adjuvant endocrine therapy for breast cancer.

Xu L, Li P, Hu Y, Xing W, Qiu J, Zhang X, Jia L, Jing F, Liu Y, Li L, Lu C. Xu L, et al. BMC Cancer. 2025 Jan 8;25(1):41. doi: 10.1186/s12885-024-13382-4. BMC Cancer. 2025. PMID: 39780104 Free article.

9

Clinical Application of PARP1 Inhibitors and Challenges in Cancer Therapy.

Luo Y, Nie M, Chen Y, Huang X, Cui X, Lin W, Xu L, Li E, Cheng Y. Luo Y, et al. Among authors: xu l. Curr Cancer Drug Targets. 2025 Jan 6. doi: 10.2174/0115680096327635241021115944. Online ahead of print. Curr Cancer Drug Targets. 2025. PMID: 39779573

10

Correspondence on " 'An eye for an eye' therapeutic strategy for cavernous sinus dural arteriovenous fistula" by Xu et al.

Xu L, Zheng J. Xu L, et al. J Neurointerv Surg. 2025 Jan 8:jnis-2024-022938. doi: 10.1136/jnis-2024-022938. Online ahead of print. J Neurointerv Surg. 2025. PMID: 39778932 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,897 results

Search Page

Filters